Hydrochlorothiazide Tablet
Product Images NDC 76282-155

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 76282-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is A Picture Of The Label Hydrochlorothiazide Tablets, Usp, 25 mg, 30 Count. (Hydrochlorothiazide 25 mg 90 Tab)

This is a description of Hydrochlorothiazide Tablets USP 25 mg manufactured by Ascent Pharmaceutical, Inc. and distributed by Exelan Pharmaceuticals, Inc. It is a prescription drug and should be stored at 20-25°C (68-77°F), in a well-closed container as defined in the USP. The tablets come in a package of 90, and the usual dosage should be determined by a healthcare provider.*

FDA Label Image

This Is A Picture Of The Label Hydrochlorothiazide Tablets, Usp, 25 mg, 30 Count. (Hydrochlorothiazide 50mg 90tab)

FDA Label Image

Hydrochlorothiazide-structure (Hydrochlorothiazide Str)

The text is providing chemical formula and molecular weight for a compound. Its name or other properties are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.